GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zhejiang Huakang Pharmaceutical Co Ltd (SHSE:605077) » Definitions » Additional Paid-In Capital

Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zhejiang Huakang Pharmaceutical Co Additional Paid-In Capital?


Zhejiang Huakang Pharmaceutical Co's annual additional paid-in capital declined from Dec. 2021 (¥1,463 Mil) to Dec. 2022 (¥1,398 Mil) and declined from Dec. 2022 (¥1,398 Mil) to Dec. 2023 (¥0 Mil).


Zhejiang Huakang Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Zhejiang Huakang Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huakang Pharmaceutical Co Additional Paid-In Capital Chart

Zhejiang Huakang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 164.41 164.41 1,463.42 1,398.15 -

Zhejiang Huakang Pharmaceutical Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,398.15 - - -

Zhejiang Huakang Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Zhejiang Huakang Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Zhejiang Huakang Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Huagong Road, Huabu Town, Zhejiang Province, Kaihua County, Quzhou, CHN, 324302
Zhejiang Huakang Pharmaceutical Co Ltd is engaged in the research and development, production and sales of various functional sugar alcohols and starch sugar products such as xylitol, sorbitol, maltitol, fructose syrup and others.
Executives
Du Yong Rui Director
Zheng Fang Ming senior management
Jiang Xue Song Supervisors
Yu Jian Ming Directors, senior managers
Chen De Shui Directors, senior managers
Xu Xiao Rong Director
Cheng Xin Ping Directors, senior managers
Yan Xiao Xing Supervisors
Cao Jian Hong Director

Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Headlines

No Headlines